Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Hypoxia | 1 | 2022 | 43 | 0.710 |
Why?
|
| Positron-Emission Tomography | 6 | 2022 | 347 | 0.630 |
Why?
|
| Optical Imaging | 2 | 2017 | 51 | 0.490 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 1073 | 0.460 |
Why?
|
| Implants, Experimental | 1 | 2013 | 16 | 0.380 |
Why?
|
| Peritoneum | 1 | 2013 | 52 | 0.380 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 64 | 0.380 |
Why?
|
| Molecular Imaging | 1 | 2013 | 72 | 0.360 |
Why?
|
| Nanoparticles | 5 | 2017 | 198 | 0.320 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2013 | 145 | 0.260 |
Why?
|
| Neoplasms | 1 | 2022 | 3169 | 0.250 |
Why?
|
| Image Enhancement | 2 | 2007 | 498 | 0.220 |
Why?
|
| Radiopharmaceuticals | 3 | 2022 | 201 | 0.210 |
Why?
|
| Transducers | 1 | 2004 | 37 | 0.210 |
Why?
|
| Neural Stem Cells | 2 | 2015 | 68 | 0.200 |
Why?
|
| Silicon Dioxide | 2 | 2017 | 39 | 0.200 |
Why?
|
| Mice | 11 | 2022 | 12224 | 0.190 |
Why?
|
| Misonidazole | 1 | 2022 | 18 | 0.180 |
Why?
|
| Glioblastoma | 2 | 2015 | 280 | 0.180 |
Why?
|
| Spectrum Analysis | 1 | 2022 | 118 | 0.180 |
Why?
|
| Cell Hypoxia | 1 | 2022 | 186 | 0.170 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2022 | 324 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 606 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2004 | 626 | 0.160 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 810 | 0.140 |
Why?
|
| Animals | 13 | 2022 | 27965 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 2 | 2013 | 368 | 0.140 |
Why?
|
| 4-Aminopyridine | 1 | 2018 | 33 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 2562 | 0.130 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 48 | 0.130 |
Why?
|
| Fluorine Radioisotopes | 1 | 2018 | 25 | 0.130 |
Why?
|
| Luminescence | 1 | 2017 | 20 | 0.130 |
Why?
|
| Hypoxia | 1 | 2022 | 672 | 0.130 |
Why?
|
| Algorithms | 2 | 2007 | 1948 | 0.130 |
Why?
|
| Mice, Nude | 3 | 2015 | 823 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 82 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 2363 | 0.120 |
Why?
|
| Colonic Polyps | 1 | 2017 | 137 | 0.120 |
Why?
|
| Potassium Channels | 1 | 2018 | 346 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2017 | 204 | 0.110 |
Why?
|
| Materials Testing | 2 | 2013 | 94 | 0.110 |
Why?
|
| Fractals | 1 | 2015 | 41 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 87 | 0.110 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 2757 | 0.110 |
Why?
|
| Multimodal Imaging | 2 | 2015 | 108 | 0.110 |
Why?
|
| Phantoms, Imaging | 4 | 2017 | 479 | 0.110 |
Why?
|
| Endoscopy | 1 | 2017 | 366 | 0.100 |
Why?
|
| Chelating Agents | 1 | 2013 | 68 | 0.100 |
Why?
|
| Polyvinyl Chloride | 1 | 2013 | 7 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 80 | 0.090 |
Why?
|
| Mitochondrial Dynamics | 1 | 2013 | 59 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2013 | 138 | 0.090 |
Why?
|
| Abdomen | 1 | 2013 | 118 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 1130 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 128 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 177 | 0.090 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2012 | 117 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 2479 | 0.090 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 24 | 0.080 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 49 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 875 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 255 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2011 | 321 | 0.080 |
Why?
|
| Simvastatin | 1 | 2010 | 106 | 0.080 |
Why?
|
| Disease Progression | 2 | 2012 | 1529 | 0.080 |
Why?
|
| Lung Injury | 1 | 2010 | 59 | 0.080 |
Why?
|
| Drug Carriers | 1 | 2010 | 88 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2010 | 156 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 1269 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 1054 | 0.070 |
Why?
|
| Humans | 12 | 2022 | 93138 | 0.070 |
Why?
|
| Spiral Cone-Beam Computed Tomography | 1 | 2007 | 8 | 0.070 |
Why?
|
| Lung | 2 | 2013 | 1359 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 393 | 0.060 |
Why?
|
| Liver | 1 | 2010 | 1206 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2013 | 1687 | 0.060 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 33 | 0.050 |
Why?
|
| Rats | 3 | 2018 | 4028 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 87 | 0.050 |
Why?
|
| Fourier Analysis | 1 | 2004 | 123 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 1022 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 125 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 194 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2705 | 0.050 |
Why?
|
| Equipment Design | 1 | 2004 | 411 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 255 | 0.050 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2013 | 64 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1980 | 0.040 |
Why?
|
| Female | 6 | 2018 | 48544 | 0.040 |
Why?
|
| Drug Delivery Systems | 2 | 2013 | 191 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1910 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1236 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 3155 | 0.040 |
Why?
|
| Radioactive Tracers | 1 | 2018 | 6 | 0.030 |
Why?
|
| Calibration | 1 | 2017 | 107 | 0.030 |
Why?
|
| Mice, Inbred A | 1 | 2017 | 21 | 0.030 |
Why?
|
| X-Rays | 1 | 2017 | 139 | 0.030 |
Why?
|
| Apoptosis | 2 | 2013 | 1719 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 116 | 0.030 |
Why?
|
| Indium Radioisotopes | 1 | 2015 | 9 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2015 | 51 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2018 | 448 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 287 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2017 | 303 | 0.030 |
Why?
|
| Colon | 1 | 2017 | 540 | 0.020 |
Why?
|
| Nanomedicine | 1 | 2013 | 16 | 0.020 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2013 | 4 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 17 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 137 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 3430 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2013 | 271 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 63 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 399 | 0.020 |
Why?
|
| Lysosomes | 1 | 2013 | 123 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 252 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 133 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2013 | 283 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 479 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 435 | 0.020 |
Why?
|
| Male | 4 | 2018 | 44357 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 233 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 398 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 27 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 40 | 0.020 |
Why?
|
| Radiation Pneumonitis | 1 | 2010 | 23 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2010 | 65 | 0.020 |
Why?
|
| Indocyanine Green | 1 | 2010 | 25 | 0.020 |
Why?
|
| Surface Properties | 1 | 2010 | 126 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 77 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 804 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1908 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 305 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 526 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 570 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1768 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1098 | 0.020 |
Why?
|
| Polymethyl Methacrylate | 1 | 2007 | 17 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2007 | 89 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 1060 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1732 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2007 | 156 | 0.020 |
Why?
|
| Extremities | 1 | 2007 | 170 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1260 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2458 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2009 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2010 | 2121 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1114 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3450 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 3891 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5379 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 10132 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 20399 | 0.010 |
Why?
|